Thus, even though this was a small clinical trial these results are in line with previous human studies indicating that regardless to the disease context (e.g. lipodystrophy, hypothalamic amenorrhea) leptin therapy is efficacious only in severely hypoleptinemic subjects40–44. The gene discussed is LEP; the disease is lipodystrophy.